Radiopharmaceuticals | Administered activity | Organ receiving the largest radiation dose MGy/MBq (rad/mCi) | Effective dose MSv/MBq (rem/mCi) | ||||
---|---|---|---|---|---|---|---|
MBq/kg (mCi/kg) | Minimum dose MBq (mCi) | Maximum dose MBq (mCi) | |||||
99mTc-DTPA* | 7.4 i.v. (0.2) | 370 (10) | 740 (20) | 0.17 bladder wall (0.63) | 0.017 (0.063) | ||
99mTc-HMPAO† | 11.1 i.v. (0.3) | 185 (5) | 740 (20) | 0.14 thyroid (0.52) | 0.026 (0.096) | ||
99mTc-ECD‡ | 11.1 i.v. (0.3) | 185 (5) | 740 (20) | 0.083 bladder wall (0.31) | 0.023 (0.085) |
↵* ICRP 53, page 188.
↵† ICRP 62, page 13.
↵‡ Radiation Dose Estimates for Radiopharmaceuticals; Radiation Internal Dose Information Center, Oak Ridge Institute for Science and Education, Oak Ridge, TN; http://www.orau.gov/ehsd/pedose.doc.
i.v. = intravenously.